Please wait while the formulary information is being retrieved.
SYNAREL (NAFARELIN ACETATE)
- Endometriosis
- Precocious puberty
2 mg/mL nasal spray
- Spray 1 spray in one nostril in the morning by intranasal route and 1Spray into the other nostril in the evening
Endometriosis
- Spray 1 spray in each nostril by intranasal route in the morning and evening for 6 months
- Spray 1 spray in each nostril by intranasal route in the morning and evening
- Spray 1 spray in one nostril in the morning by intranasal route and 1Spray into the other nostril in the evening for 6 months
- Spray 1 spray in one nostril in the morning by intranasal route and 1Spray into the other nostril in the evening
- None
Contraindicated
- None
Severe
Moderate
- None
- Lactating mother
- Pregnancy
Contraindicated
- None
Severe
Moderate
- Alcoholism
- Diabetes mellitus
- Hypercholesterolemia
- Hypertension
- Increased cardiovascular event risk
- Obesity
- Osteopenia
- Osteoporosis
- Tobacco smoker
SYNAREL (NAFARELIN ACETATE)
- Endometriosis
- Precocious puberty
- Menorrhagia
- Abnormal vaginal bleeding
- Acne vulgaris
- Amenorrhea
- Flushing
- Hypoestrogenism
- Weight gain
More Frequent
Severe
Less Severe
- Osteopenia
- Headache disorder
- Hyperlipidemia
- Maculopapular rash
- Mood changes
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute myocardial infarction
- Allergic dermatitis
- Cerebrovascular accident
- Deep venous thrombosis
- Diabetes mellitus
- Dyspnea
- Hepatocellular damage
- Ovarian cyst
- Ovarian enlargement
- Ovarian hyperstimulation syndrome
- Pituitary apoplexy
- Pulmonary thromboembolism
- Seizure disorder
- Suicidal ideation
- Transient cerebral ischemia
- Urticaria
Less Severe
- Aggressive behavior
- Agitation
- Arthralgias
- Body odor
- Breast engorgement
- Chloasma
- Depression
- Galactorrhea not associated with childbirth
- General weakness
- Hostility
- Irritability
- Mastalgia
- Ocular pain
- Pruritus of skin
- Rhinitis
- Seborrhea
- Weight loss
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Nafarelin Acetate
- Severity Level:
X
- Additional Notes: Contraindicated: perform pregnancy test prior to use.
Contraindicated
Nafarelin Acetate
Contraindicated by manufacturer
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Contraindicated by manufacturer |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Endometriosis | |
| N80 | Endometriosis |
| N80.0 | Endometriosis of uterus |
| N80.1 | Endometriosis of ovary |
| N80.2 | Endometriosis of fallopian tube |
| N80.3 | Endometriosis of pelvic peritoneum |
| N80.4 | Endometriosis of rectovaginal septum and vagina |
| N80.5 | Endometriosis of intestine |
| N80.6 | Endometriosis in cutaneous scar |
| N80.8 | Other endometriosis |
| N80.9 | Endometriosis, unspecified |
| Precocious puberty | |
| E30.1 | Precocious puberty |
| 0-9 | A-Z |
|---|---|
| E30.1 | Precocious puberty |
| N80 | Endometriosis |
| N80.0 | Endometriosis of uterus |
| N80.1 | Endometriosis of ovary |
| N80.2 | Endometriosis of fallopian tube |
| N80.3 | Endometriosis of pelvic peritoneum |
| N80.4 | Endometriosis of rectovaginal septum and vagina |
| N80.5 | Endometriosis of intestine |
| N80.6 | Endometriosis in cutaneous scar |
| N80.8 | Other endometriosis |
| N80.9 | Endometriosis, unspecified |
Formulary Reference Tool